CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation
Year: 2020
Type: article
Source: Molecular Cancer Therapeutics
Authors: Kenji Kashima, Hiroki Kawauchi, Hiromi Tanimura, Yukako Tachibana, Takashi Chiba, Takuya Torizawa, Hiroshi Sakamoto
Institution: Chugai Pharmaceutical Co., Ltd. (Japan)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Roche, Chugai Pharmaceutical
OpenAlex ID: W3087185067
